# Cognitive Impairment in Treated Breast Cancer Survivors: Possible Approaches

> **NCT06662474** · NA · NOT_YET_RECRUITING · sponsor: **Grigore T. Popa University of Medicine and Pharmacy** · enrollment: 120 (estimated)

## Conditions studied

- Cognitive Impairment
- Chemobrain

## Interventions

- **OTHER:** 1. cognitive stimulation
- **OTHER:** 2. psychoeducation and cognitive stimulation
- **OTHER:** 3. no intervention

## Key facts

- **NCT ID:** NCT06662474
- **Lead sponsor:** Grigore T. Popa University of Medicine and Pharmacy
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2026-11-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06662474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06662474, "Cognitive Impairment in Treated Breast Cancer Survivors: Possible Approaches". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06662474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*